- Investing Ideas
- /
- Healthcare Sector
Healthcare Sector
UPDATED Apr 21, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,557 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ALGN | US$298.98 | -1.9% | -17.7% | US$22.5b | US$320.95 | PE50.6x | E14.7% | n/a | Healthcare | ||
MOH | US$367.52 | 1.8% | 29.6% | US$21.5b | US$418.19 | PE19.7x | E14.7% | n/a | Healthcare | ||
BNTX | US$86.81 | -1.2% | -25.8% | US$20.9b | US$113.37 | PE21.1x | E-20.2% | n/a | Pharmaceuticals & Biotech | ||
BAX | US$39.47 | -1.4% | -13.1% | US$20.1b | US$47.40 | PS1.4x | E35.1% | 2.9% | Healthcare | ||
STE | US$199.51 | -0.8% | 6.4% | US$19.7b | US$238.17 | PE34.8x | E13.9% | 1.0% | Healthcare | ||
ILMN | US$117.43 | -3.1% | -48.7% | US$18.7b | US$159.53 | PS4.2x | E68.4% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$144.41 | -2.2% | -29.5% | US$18.3b | US$220.00 | PS10x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
COO | US$90.42 | -1.8% | -6.2% | US$18.0b | US$107.90 | PE61.8x | E21.9% | 0% | Healthcare | ||
HOLX | US$75.38 | -2.8% | -12.0% | US$17.7b | US$84.27 | PE34.4x | E13.0% | n/a | Healthcare | ||
WAT | US$296.10 | -7.4% | -4.5% | US$17.6b | US$325.30 | PE27.3x | E6.5% | n/a | Pharmaceuticals & Biotech | ||
LH | US$201.48 | -0.9% | -13.3% | US$16.9b | US$243.81 | PE44.7x | E24.4% | 1.4% | Healthcare | ||
RPRX | US$28.16 | -0.3% | -21.4% | US$16.8b | US$45.40 | PE11.1x | E6.0% | 3.0% | Pharmaceuticals & Biotech | ||
BMRN | US$88.63 | -3.1% | -7.8% | US$16.8b | US$110.42 | PE100.3x | E30.9% | n/a | Pharmaceuticals & Biotech | ||
AVTR | US$24.10 | -2.5% | 19.6% | US$16.4b | US$27.85 | PE51x | E27.2% | n/a | Pharmaceuticals & Biotech | ||
TEVA | US$12.86 | -2.8% | 54.0% | US$14.6b | US$15.74 | PB1.9x | E32.1% | 0% | Pharmaceuticals & Biotech | ||
DGX | US$128.44 | -0.2% | -12.4% | US$14.3b | US$142.29 | PE16.8x | E8.2% | 2.3% | Healthcare | ||
BGNE | US$129.52 | -6.4% | -49.7% | US$13.5b | US$268.64 | PS5.5x | E56.2% | n/a | Pharmaceuticals & Biotech | ||
VTRS | US$11.25 | -0.6% | 20.6% | US$13.4b | US$12.40 | PE244.2x | E16.0% | 4.3% | Pharmaceuticals & Biotech | ||
COH | AU$323.05 | 1.5% | 28.4% | AU$20.7b | AU$280.94 | PE60.4x | E12.2% | 1.2% | Healthcare | ||
NBIX | US$132.00 | 0.2% | 27.5% | US$13.3b | US$152.48 | PE53.2x | E26.6% | n/a | Pharmaceuticals & Biotech | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
RVTY | US$100.86 | -1.4% | -25.2% | US$12.5b | US$123.11 | PE69.4x | E24.1% | 0.3% | Pharmaceuticals & Biotech | ||
SWAV | US$329.00 | 0.6% | 16.3% | US$12.3b | US$294.27 | PE83.8x | E19.9% | n/a | Healthcare | ||
INCY | US$52.35 | -2.0% | -30.4% | US$11.8b | US$75.68 | PE19.7x | E20.1% | n/a | Pharmaceuticals & Biotech |